PacBio to discuss Q2 2026 financial results on August 5
PacBio will host a conference call on August 5, 2026, to discuss its Q2 2026 financial results. The call begins at 4:30 p.m. ET and will be webcast live.
*this image is generated using AI for illustrative purposes only.
PacBio announced it will hold a conference call to discuss its second quarter 2026 financial results on Wednesday, August 5, 2026, at 4:30 p.m. Eastern Time. The event provides investors and analysts with an opportunity to review the company's performance for the quarter.
The discussion will be accessible via a live webcast on PacBio’s investor relations website. Participants can also join the call by phone using the provided domestic and international dial-in numbers.
Conference Call Details
| Detail | Information |
|---|---|
| Date | Wednesday, August 5, 2026 |
| Time (Eastern) | 4:30 p.m. ET |
| Time (Pacific) | 1:30 p.m. PT |
| Webcast | investor.pacificbiosciences.com |
| Toll-free Number | 1-888-349-0136 |
| International Number | 1-412-317-0459 |
PacBio designs, develops, and manufactures advanced sequencing solutions for scientists and clinical researchers. Its technologies, including HiFi long-read sequencing, are used in applications such as human germline sequencing, plant and animal sciences, and oncology.
Investors seeking further information can contact the company at ir@pacb.com , while media inquiries should be directed to pr@pacb.com .
What key performance indicators will investors focus on during the Q2 2026 earnings call?
How might PacBio's HiFi long-read sequencing technology impact its market position in the coming years?
What are the expected growth drivers for PacBio in the oncology and clinical research sectors?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
